Why Are Women Still Not Told Their Options for Fibroids?
- Georgie Kovacs
- 5 days ago
- 2 min read
Uterine Fibroids: What You’re Not Being Told About Your Treatment Options
Uterine fibroids affect up to 80% of women by age 50, yet most are not given the full range of treatment options. In this episode, I speak with leading fibroid experts—including minimally invasive surgeons, interventional radiologists, and advocates—to unpack the medical, financial, and structural reasons why hysterectomy is so often pushed as the default solution.
Whether you’re trying to preserve fertility, manage chronic pain, or simply want to know what questions to ask at your next appointment, this episode is a must-listen.
What We Cover in This Episode
What uterine fibroids are and who they affect most
The different types of fibroid treatment (UFE, myomectomy, hormonal therapy, hysterectomy)
Why UFE is still underutilized despite being a first-line treatment
How reimbursement structures impact the care women receive
How to prepare for your appointment and advocate for yourself
What a true multidisciplinary care model looks like
The connection between fibroid care and larger women’s health equity issues
Expert Guests Featured
Dr. Jessica Opoku-Anane – Minimally Invasive GYN Surgeon, Columbia
Dr. Marc Schiffman – Co-Executive Director, Weill Cornell Medicine Fibroid Center
Tanika Gray Valbrun – Founder, The White Dress Project and fibroid awareness advocate
Key Takeaways
Ask about all options before agreeing to surgery
Consider seeing a center that includes interventional radiologists and minimally invasive surgeons
Your experience and symptoms are valid—even if you’ve been told “it’s normal”
Tracking your symptoms before appointments helps you get better care
Insurance coverage and doctor training gaps often limit what gets recommended
Resources Mentioned
Connect With Us
Subscribe to the Fempower Health newsletter for tools, research, and stories that help you navigate the healthcare system with clarity and confidence.
コメント